Lung transplantation in the management of patients with lymphangioleiomyomatosis: baseline data from the NHLBI LAM Registry.

[1]  G. Beck,et al.  The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. , 2006, American journal of respiratory and critical care medicine.

[2]  A. Geha,et al.  The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. , 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[3]  G. Patterson,et al.  Lung transplantation for lymphangioleiomyomatosis. , 2001, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[4]  D. Johnson,et al.  Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume. , 2000, Respiratory medicine.

[5]  J. Lacronique,et al.  Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). , 1999, Medicine.

[6]  R. Speich,et al.  Lung transplantation for lymphangioleiomyomatosis. , 1996, The New England journal of medicine.

[7]  John L. Hankinson,et al.  Standardization of Spirometry, 1994 Update. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[8]  A. Miller,et al.  Lung function testing: selection of reference values and interpretative strategies. , 1992, The American review of respiratory disease.